Loading the section…

MESO: financial statements from SEC — TradeAlmanac

MESO

Mesoblast Limited: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	30/06/2025	30/06/2024	30/06/2023	30/06/2022	30/06/2021	30/06/2020	30/06/2019
Revenue	17M	6M	8M	10M	7M	32M	17M
Cost of revenue	5M	0	0	—	—	—	—
Research and development	35M	40M	53M	33M	53M	56M	60M
Selling, general and administrative	39M	25M	27M	—	—	—	—
Interest expense	22M	21M	19M	17M	16M	15M	12M
Pre-tax income	−102M	−88M	−82M	−92M	−100M	−87M	−99M
Income tax	330,000	−191,000	−212,000	−239,000	−819,000	−9M	−9M
Net income	−102M	−88M	−82M	−91M	−99M	−78M	−90M
Earnings per share	−0.08	−0.09	−0.11	−0.13	−0.16	−0.15	−0.18
Earnings per share, diluted	−0.08	−0.09	−0.11	−0.13	−0.16	−0.15	−0.18
Weighted average shares	1.21B	987M	778M	683M	605M	529M	494M

Balance sheet

Metric	18/08/2026	30/06/2025	30/06/2024	30/06/2023	30/06/2022	30/06/2021	30/06/2020	30/06/2019
Cash and equivalents	—	162M	63M	71M	60M	137M	129M	50M
Receivables	—	15M

Cash flow

Metric	30/06/2025	30/06/2024	30/06/2023	30/06/2022	30/06/2021	30/06/2020	30/06/2019
Operating cash flow	−50M	−48M	−63M	−66M	−101M	−50M	−58M
Depreciation and amortisation	6M	5M	4M	4M

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator